Several studies have found association between COX-2 expression and aromatase expression at the transcriptional level [35,36,48], and at the protein level using IHC [27,49,50], supporting that COX-2 may be used as a surrogate marker for aromatase content in tumor tissue [41]. Here, PTGS2 is linked to neoplasm.